Investor Relations
Public market access to revolutionary medical innovation
Welcome to the Investor Centre
Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Our main goals are to make a difference to patients' lives and generate a superior return for our investors.
Latest Presentation
Latest Annual Report
Annual Report and Accounts
For the year ended 31st Dec 2021
Highlights
£226m
NAV (at 31 Dec 2022)
175p
NAV per share (at 31 Dec 2022)
£123m
Cash (at 31 Dec 2022)
£99.6m
GPV (at 31 Dec 2022)
LON:ARIX